4.2 Article

Mechanism of action of agomelatine: a novel antidepressant exploiting synergy between monoaminergic and melatonergic properties

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

Agomelatine Versus Venlafaxine XR in the Treatment of Anhedonia in Major Depressive Disorder A Pilot Study

Giovanni Martinotti et al.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)

Article Pharmacology & Pharmacy

Comparison of agomelatine and escitalopram on nighttime sleep and daytime condition and efficacy in major depressive disorder patients

Maria-Antonia Quera-Salva et al.

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2011)

Article Psychology, Clinical

Agomelatine in the Treatment of Major Depressive Disorder: An 8-Week, Multicenter, Randomized, Placebo-Controlled Trial

Stephen M. Stahl et al.

JOURNAL OF CLINICAL PSYCHIATRY (2010)

Article Pharmacology & Pharmacy

A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR

Sidney H. Kennedy et al.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)

Review Clinical Neurology

The other face of depression, reduced positive affect: the role of catecholamines in causation and cure

David Nutt et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2007)